Page last updated: 2024-11-12

sybr green i

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

SYBR Green I: binds to double stranded DNA of less than 20 pg following agarose or polyacrylamide gel electrophoresis; excited at 497 nm and emits at 520 nm [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

SYBR Green I : A benzothiazolium ion resulting from the methylation of the nitrogen of the benzothiazole group of N-[4-(1,3-benzothiazol-2-ylmethylene)-1-phenyl-1,4-dihydroquinolin-2-yl]-N',N'-dimethyl-N-propylpropane-1,3-diamine. A cationic unsymmetrical cyanine dye that binds to double-stranded DNA and is used as a nucleic acid stain in molecular biology. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID57448928
CHEBI ID51461
SCHEMBL ID16758374
MeSH IDM0257560

Synonyms (9)

Synonym
2-{(e)-[2-{[3-(dimethylamino)propyl](propyl)amino}-1-phenylquinolin-4(1h)-ylidene]methyl}-3-methyl-1,3-benzothiazol-3-ium
CHEBI:51461
(e)-2-((2-((3-(dimethylamino)propyl)(propyl)amino)-1-phenylquinolin-4(1h)-ylidene)methyl)-3-methylbenzo[d]thiazol-3-ium
2-[n-(3-dimethylaminopropyl)-n-propylamino]-4-[2,3-dihydro-3-methyl-(benzo-1,3-thiazol-2-yl)-methylidene]-1-phenyl-quinolinium
2-{[3-(dimethylamino)propyl](propyl)amino}-4-[(e)-(3-methyl-1,3-benzothiazol-2(3h)-ylidene)methyl]-1-phenylquinolinium
sybr green i
SCHEMBL16758374
2-((3-(dimethylamino)propyl)(propyl)amino)-4-((3-methylbenzo[d]thiazol-2(3h)-ylidene)methyl)-1-phenylquinolin-1-ium
178918-96-2

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" However, the RSA has several drawbacks: it is relatively low throughput, has high variance due to microscopy readout, and correlates poorly with the current benchmark for in vivo resistance, patient clearance half-life post-artemisinin treatment."( The extended recovery ring-stage survival assay provides a superior association with patient clearance half-life and increases throughput.
Anderson, TJC; Button-Simons, KA; Cassady, Z; Checkley, LA; Davis, SZ; Ferdig, MT; Foster, GJ; McDew-White, M; Nosten, FH; Shoue, DA; Sievert, MAC; Singh, PP; Vendrely, KM, 2020
)
0.56
" Due to the large number of pyknotic and dying parasites at 66 h post-exposure (72 h sample), parasites were grown for an additional cell cycle (114 h post-exposure, 120 h sample), which drastically improved correlation with patient clearance half-life compared to the 66 h post-exposure sample."( The extended recovery ring-stage survival assay provides a superior association with patient clearance half-life and increases throughput.
Anderson, TJC; Button-Simons, KA; Cassady, Z; Checkley, LA; Davis, SZ; Ferdig, MT; Foster, GJ; McDew-White, M; Nosten, FH; Shoue, DA; Sievert, MAC; Singh, PP; Vendrely, KM, 2020
)
0.56

Compound-Compound Interactions

The malaria Sybr green I-based fluorescence (MSF) assay for its use in in vitro drug combination sensitivity assays. The most effective method was combined with a real-time PCR method based on the double-stranded DNA binding dye SYBR Green I used with the ABI Prism 7700 system.

ExcerptReferenceRelevance
" The most effective method was then combined with a real-time PCR method based on the double-stranded DNA binding dye SYBR Green I used with the ABI Prism 7700 system."( Evaluation of DNA extraction methods for use in combination with SYBR green I real-time PCR to detect Salmonella enterica serotype enteritidis in poultry.
Croci, L; De Medici, D; Delibato, E; Di Pasquale, S; Filetici, E; Toti, L, 2003
)
0.32
" We evaluated the malaria Sybr green I-based fluorescence (MSF) assay for its use in in vitro drug combination sensitivity assays."( Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay.
Co, EM; Dennull, RA; Johnson, JD; Reinbold, DD; Waters, NC, 2009
)
0.35
"Dear Sir, A single tube polymerase chain reaction (PCR) with three primers and SYBR GREEN1 combined with dissociation curve analysis was set up that can clearly differentiate between Hb Bart's hydrops fetalis, normal subjects and - -(SEA) heterozygotes."( Rapid diagnosis of the alpha-thalassemia-1 Southeast Asian type deletion using a single tube real-time SYBR-polymerase chain reaction combined with dissociation curve analysis.
Liu, JZ; Wang, LR; Wang, QT; Xiao, B, 2009
)
0.35
" In this system, a newly designed inexpensive DNA extraction device was used in combination with a modified visual loop-mediated isothermal amplification (vLAMP) assay."( One simple DNA extraction device and its combination with modified visual loop-mediated isothermal amplification for rapid on-field detection of genetically modified organisms.
Chen, L; Jiang, S; Liu, Y; Quan, S; Yang, L; Zhang, D; Zhang, M, 2013
)
0.39

Dosage Studied

ExcerptRelevanceReference
"Mutations and altered gene dosage of the peripheral myelin protein (PMP22) gene in chromosome 17p11."( Rapid detection of duplication/deletion of the PMP22 gene in patients with Charcot-Marie-Tooth disease Type 1A and hereditary neuropathy with liability to pressure palsy by real-time quantitative PCR using SYBR Green I dye.
Jin, HS; Jung, SC; Kim, SW; Koo, SK; Lee, KS; Lee, TM; Lee, YJ, 2003
)
0.32
" In addition, gene dosage was analyzed using multiplex ligation-dependent probe amplification (MLPA) method in all suspected carriers."( Detection of unknown deletions in beta-globin gene cluster using relative quantitative PCR methods.
Alimohammadi, R; Babashah, S; Jamali, S; Karimipoor, M; Mahdian, R; Maryami, F; Masoudifar, M; Nosaeid, MH; Raeisi, M; Zeinali, S, 2009
)
0.35
" The aim of this study was to apply a gene dosage approach, using SYBR green quantitative real-time polymerase chain reaction (RT-PCR), to quantify the genomic copy number in carriers and noncarriers of gross deletions covering the region of the CYBB gene."( Identification of deletion carriers in X-linked chronic granulomatous disease by real-time PCR.
Chiriaco, M; D'Argenio, P; Di Matteo, G; Finocchi, A; Folgori, L; Giardina, E; Nardone, AM; Rossi, P; Sinibaldi, C, 2009
)
0.35
" Here we demonstrate the use of Exciton Primers for genotyping a single nucleotide polymorphism (SNP) in the VKORC1 locus (-1639G>A) relevant for Warfarin dosing as an example for Exciton Primers mediated genotyping by SmartAmp2."( Exciton Primer-mediated SNP detection in SmartAmp2 reactions.
Hanami, T; Harbers, M; Hayashizaki, Y; Ikeda, S; Ishidao, T; Ishizu, Y; Itoh, M; Katayama, A; Kogo, Y; Lezhava, A; Mitani, Y; Murakami, K; Naito, K; Nogawa, C; Okamoto, A; Soma, T, 2010
)
0.36
" Large deletions in APC are a common cause of FAP; despite the existence of a variety of gene dosage detection methodologies, most are labor intensive and time and resource consuming."( A novel SYBR-based duplex qPCR for the detection of gene dosage: detection of an APC large deletion in a familial adenomatous polyposis patient with an unusual phenotype.
Carraro, DM; da Silva, FC; dos Santos, EM; Krepischi, AC; Rossi, BM; Torrezan, GT, 2012
)
0.38
"We describe a new duplex qPCR method for gene dosage analysis based on the coamplification of a target and a reference gene in a SYBR Green reaction, followed by a comparison of the ratio between the target and the reference peaks of the melting curve for the test (patient) and control samples."( A novel SYBR-based duplex qPCR for the detection of gene dosage: detection of an APC large deletion in a familial adenomatous polyposis patient with an unusual phenotype.
Carraro, DM; da Silva, FC; dos Santos, EM; Krepischi, AC; Rossi, BM; Torrezan, GT, 2012
)
0.38
"Using this novel gene dosage method, we have identified an APC gene deletion in a FAP patient undergoing genetic testing."( A novel SYBR-based duplex qPCR for the detection of gene dosage: detection of an APC large deletion in a familial adenomatous polyposis patient with an unusual phenotype.
Carraro, DM; da Silva, FC; dos Santos, EM; Krepischi, AC; Rossi, BM; Torrezan, GT, 2012
)
0.38
"The novel assay accurately detected losses and gains of one copy of the target sequences, representing a reliable and flexible alternative to other gene dosage techniques."( A novel SYBR-based duplex qPCR for the detection of gene dosage: detection of an APC large deletion in a familial adenomatous polyposis patient with an unusual phenotype.
Carraro, DM; da Silva, FC; dos Santos, EM; Krepischi, AC; Rossi, BM; Torrezan, GT, 2012
)
0.38
" The half maximal inhibitory concentration (IC50) was calculated from dose-response curves."( [Assessment of Antimalarial Activity of Choline Derivatives against Plasmodium falciparum Growth in vitro by SYBR Green I Method].
Cheng, HF; Gao, J; Wang, RL; Zhang, SQ; Zhao, Q, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
fluorescent dyenull
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
cyanine dyeCyanine dyes are synthetic dyes with the general formula R2N[CH=CH]nCH=N(+)R2 <-> R2N(+)=CH[CH=CH]nNR2 (n is a small number) in which the nitrogen and part of the conjugated chain usually form part of a heterocyclic system, such as imidazole, pyridine, pyrrole, quinoline and thiazole.
tertiary amineA compound formally derived from ammonia by replacing three hydrogen atoms by hydrocarbyl groups.
quinolinesA class of aromatic heterocyclic compounds each of which contains a benzene ring ortho fused to carbons 2 and 3 of a pyridine ring.
benzothiazolium ion
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (1,084)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's34 (3.14)18.2507
2000's471 (43.45)29.6817
2010's478 (44.10)24.3611
2020's101 (9.32)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.09%)5.53%
Reviews10 (0.90%)6.00%
Case Studies4 (0.36%)4.05%
Observational0 (0.00%)0.25%
Other1,097 (98.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]